NO932815L - Lipoksygenase-inhiberende hydroksamsyre og n-hydroksy-urinstoffderivater - Google Patents

Lipoksygenase-inhiberende hydroksamsyre og n-hydroksy-urinstoffderivater

Info

Publication number
NO932815L
NO932815L NO93932815A NO932815A NO932815L NO 932815 L NO932815 L NO 932815L NO 93932815 A NO93932815 A NO 93932815A NO 932815 A NO932815 A NO 932815A NO 932815 L NO932815 L NO 932815L
Authority
NO
Norway
Prior art keywords
hydroxy
hydrogen
lipoxygenase
inhibiting
alkenyl
Prior art date
Application number
NO93932815A
Other languages
English (en)
Norwegian (no)
Other versions
NO932815D0 (no
Inventor
Rodney William Stevens
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO932815D0 publication Critical patent/NO932815D0/no
Publication of NO932815L publication Critical patent/NO932815L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Lubricants (AREA)
NO93932815A 1991-02-07 1993-08-06 Lipoksygenase-inhiberende hydroksamsyre og n-hydroksy-urinstoffderivater NO932815L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3016325A JPH0730061B2 (ja) 1991-02-07 1991-02-07 ヒドロキサム酸誘導体および組成物
PCT/US1992/000027 WO1992013848A1 (en) 1991-02-07 1992-01-08 Lipoxygenase-inhibiting hydroxamic acid and n-hydroxyurea derivatives

Publications (2)

Publication Number Publication Date
NO932815D0 NO932815D0 (no) 1993-08-06
NO932815L true NO932815L (no) 1993-08-09

Family

ID=11913313

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93932815A NO932815L (no) 1991-02-07 1993-08-06 Lipoksygenase-inhiberende hydroksamsyre og n-hydroksy-urinstoffderivater

Country Status (21)

Country Link
EP (1) EP0570401B1 (de)
JP (1) JPH0730061B2 (de)
KR (1) KR930703279A (de)
AT (1) ATE113942T1 (de)
AU (1) AU648872B2 (de)
CA (1) CA2101539A1 (de)
DE (1) DE69200665T2 (de)
DK (1) DK0570401T3 (de)
ES (1) ES2063578T3 (de)
FI (1) FI933492L (de)
HU (1) HUT65539A (de)
IE (1) IE920392A1 (de)
IL (1) IL100846A0 (de)
MX (1) MX9200519A (de)
MY (1) MY134478A (de)
NO (1) NO932815L (de)
NZ (1) NZ241530A (de)
PT (1) PT100093A (de)
TW (1) TW222627B (de)
WO (1) WO1992013848A1 (de)
ZA (1) ZA92862B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639782A (en) * 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
US5463083A (en) 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
HUT72601A (en) 1992-07-13 1996-05-28 Cytomed Inc 2,5-diaryl tetrahydro-thiophenes-furans and analogs for the treatment of inflammatory and immune disorders
US5750565A (en) 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
EE9600184A (et) * 1994-06-27 1997-06-16 Cytomed, Inc. Kardiovaskulaar-, inflammatoor- ja immuunhaiguste raviühendid ja -meetodid
US6201016B1 (en) * 1994-06-27 2001-03-13 Cytomed Incorporated Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
MX9701042A (es) * 1996-02-07 1998-05-31 Pfizer Compuestos del acido hidroxamico.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1044308A (en) * 1964-04-28 1966-09-28 Langbein Pfanhauser Werke Ag Electrodeposition of bright copper
US3393209A (en) * 1965-10-04 1968-07-16 Dow Chemical Co Furfuryl and tetrahydrofurfuryl phenyl ureas
JPS5742632B2 (de) * 1972-12-25 1982-09-09
DE3882732T2 (de) * 1987-02-10 1993-12-02 Abbott Lab Indol, Benzofuran, Benzothiophen enthaltende, Lipoxygenase hemmende Verbindungen.
GB2201008B (en) * 1987-02-12 1991-10-23 Stc Plc Optical fibre cables

Also Published As

Publication number Publication date
ES2063578T3 (es) 1995-01-01
DE69200665D1 (de) 1994-12-15
KR930703279A (ko) 1993-11-29
WO1992013848A1 (en) 1992-08-20
NO932815D0 (no) 1993-08-06
EP0570401A1 (de) 1993-11-24
ZA92862B (en) 1993-08-06
FI933492A7 (fi) 1993-08-06
JPH0730061B2 (ja) 1995-04-05
TW222627B (de) 1994-04-21
CA2101539A1 (en) 1992-08-08
AU1173692A (en) 1992-09-07
JPH04257571A (ja) 1992-09-11
PT100093A (pt) 1993-03-31
FI933492A0 (fi) 1993-08-06
IE920392A1 (en) 1992-08-12
IL100846A0 (en) 1992-11-15
MY134478A (en) 2007-12-31
HU9302283D0 (en) 1993-10-28
NZ241530A (en) 1994-06-27
HUT65539A (en) 1994-06-28
FI933492L (fi) 1993-08-06
EP0570401B1 (de) 1994-11-09
MX9200519A (es) 1992-08-31
ATE113942T1 (de) 1994-11-15
AU648872B2 (en) 1994-05-05
DE69200665T2 (de) 1995-04-06
DK0570401T3 (da) 1994-12-05

Similar Documents

Publication Publication Date Title
NO960393L (no) Heterosykliske fenylforbindelser som COX-2-inhibitorer
EP1104764A4 (de) 1h-imidazopyridin-derivate
NO331002B1 (no) Tioxantinderivater og farmasoytiske preparater med tioxantinderivater
NO963506L (no) 4-Heterocyklyl-substituerte kinazolin-derivater, fremgangsmåte for fremstilling derav og deres anvendelse som anti-kreftmidler
EA199800541A1 (ru) Ингибиторы металлопротеиназы, фармацевтические соединения, их содержащие, и их фармацевтические применения, а также способы и промежуточные соединения, пригодные для их пригоовления
HUT72653A (en) N-acyl-sulfamic acid esters (or thioesters), n-acyl-sulfonamides and n-sulfonyl-carbamic-acid-esters (or thioesters) and pharmaceutical compositions of hypercholesterolemic activity containing them
NO972307L (no) Matriksmetallproteaseinhibitorer
NO932815L (no) Lipoksygenase-inhiberende hydroksamsyre og n-hydroksy-urinstoffderivater
NO983992L (no) Serinprotease inhibitorer
ATE211468T1 (de) Neuraminsäuredervate, ihre herstellung und medizinische verwendung
ATE145906T1 (de) Benzamid-derivate
NO168243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
DK0688218T3 (da) Interleukin-1-inhibitor
AU6454196A (en) Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels
DE69522118D1 (de) Thiazolidonon- oder oxazolidinonderivate zur behandlung von angina pectoris und zusammensetzungen die diese als wirkstoffe enthält
NO985974L (no) Piperidineddiksyrederivater og deres anvendelse ved behandling av trombose-sykdommer
FI932188A0 (fi) Oktahydronaftalenoximderivat foer inhibering av kolesterolbiosyntesen, deras framstaellning och anvaendning
US4942170A (en) 2-(substituted methylidene)-N-[3-[piperidin-1-yl]propyl]hydrazine carboximidamides useful as antiparasitics
NO992316L (no) Benzensulfonamidderivater og legemidler inneholdende disse
KR950702533A (ko) 리폭시게나제 억제제로서의 인돌리닐 n-하이드록시우레아 및 n-하이드록삼산 유도체(indolinyl n-hydroxyurea and n-hydroxamic acid derivatives as lipoxygenase inhibitors)
DE3889820D1 (de) Sulfonamidderivate, Inhibitoren für das Aldose-Reduktase-Enzymsystem und diese enthaltende pharmazeutische Zusammenstellungen.
NO960308L (no) Terapeutisk aktive benzoksaziner og benzotioanoner
SE9401965D0 (sv) New compounds
US5145975A (en) Naphthoquinone derivatives
NO20004679L (no) Farmasøytisk sammensetning inneholdende en cystein- proteasehemmer for forebygging og terapi av hjernevevsforringelse